<DOC>
	<DOCNO>NCT01937130</DOCNO>
	<brief_summary>The study evaluate pharmacokinetics , pharmacodynamics , safety preliminary efficacy IDN-6556 subject cirrhosis liver hospitalize 24 hour due acute deterioration liver function .</brief_summary>
	<brief_title>Pharmacokinetic Pharmacodynamic Study IDN-6556 ACLF</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<criteria>Male female subject minimum adult legal age ( accord local law sign informed consent document ) , able provide write informed consent , understand comply requirement study Subjects clinical , radiological and/or histological diagnosis cirrhosis Subjects require hospital admission within 4 week screen complication cirrhosis Subjects acute deterioration liver function Subjects meet one follow criterion : 1 . Subjects renal failure ( defined creatinine ≥ 2.0 ≤ 3.4 mg/dL ) 2 . Subjects single organ failure i. Renal impairment ( defined increase creatinine &gt; 0.3 mg/dL either establish prior Baseline level applicable , upon admission hospital prior level unavailable ; inclusion , creatinine level must raise normal level ) , and/or ii . Hepatic encephalopathy grade I II 3 . Subjects two organ failure If subject receive steroid alcoholinduced acute liver failure , he/she must unresponsive steroid therapy . Responsiveness base investigator discretion . Willingness utilize two reliable form contraception ( male females childbearing potential ) screen one month last dose study drug Known infection HIV Subjects cirrhosis develop decompensation time postoperative period follow partial hepatectomy Subjects evidence uncontrolled infection define persistent bacterial culture positivity despite adequate antibiotic therapy Subjects clinical evidence disseminate intravascular coagulation Subjects chronic and/or preexist kidney disease define eGFR ( estimate glomerular filtration rate ) le 30 mL/min 3 month long Subjects hypotensive ( defined mean arterial pressure &lt; 70 mmHg ) require use inotropic support Subjects evidence significant and/or uncontrolled bleeding Subjects require mechanical ventilation Subjects active history malignancy hepatocellular carcinoma ( HCC ) within Milan criterion curatively treat skin cancer ( basal cell squamous cell carcinoma ) , unless adequately treated complete remission five year Subjects previously expose IDN6556 History presence clinically concern cardiac arrhythmia , prolongation Screening ( pretreatment ) QT QTc interval &gt; 480 millisecond ( msec )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Liver Failure</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Alcoholic Hepatitis</keyword>
</DOC>